Tandem Diabetes Care (MEX:TNDM) Ending Cash Position: MXN1,096 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:TNDM Tandem Diabetes Care Inc MEX:TNDM
69 GF Score
Price MXN745.00
GF Value MXN835.73
! 6 Warning Signs
View Full Analysis

What is Tandem Diabetes Care Ending Cash Position?

Tandem Diabetes Care MEX:TNDM 69 Ending Cash Position is MXN1,096 Mil as of Jun. 2026. GuruFocus rates MEX:TNDM with a GF Score™ of 69/100 and a GF Value™ of MXN835.73. The stock has 6 warning signs investors should review.

Tandem Diabetes Care's Ending Cash Position for the quarter that ended in Jun. 2026 was MXN1,096 Mil.

Tandem Diabetes Care's quarterly Ending Cash Position increased from Dec. 2025 (MXN1,632 Mil) to Mar. 2026 (MXN3,234 Mil) but then declined from Mar. 2026 (MXN3,234 Mil) to Jun. 2026 (MXN1,096 Mil).

Tandem Diabetes Care's annual Ending Cash Position increased from Dec. 2023 (MXN999 Mil) to Dec. 2024 (MXN1,444 Mil) and increased from Dec. 2024 (MXN1,444 Mil) to Dec. 2025 (MXN1,632 Mil).

Tandem Diabetes Care Ending Cash Position Related Terms

Tandem Diabetes Care Ending Cash Position Historical Data

* Premium members only.

The historical data trend for Tandem Diabetes Care's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tandem Diabetes Care Ending Cash Position Chart

Tandem Diabetes Care Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,460.21 3,363.39 999.24 1,443.92 1,631.93

Tandem Diabetes Care Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,207.18 1,686.69 1,631.93 3,233.71 1,096.11
MEX:TNDM
69GF Score
Tandem Diabetes Care Inc MEX:TNDM
Ending Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tandem Diabetes Care Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Tandem Diabetes Care's Ending Cash Position for the fiscal year that ended in Dec. 2025 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=1246.607+385.322
=1,632

Tandem Diabetes Care's Ending Cash Position for the quarter that ended in Jun. 2026 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=3129.042+-2032.931
=1,096

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of MXN1,096 Mil mean?
Tandem Diabetes Care (MEX:TNDM) has a Ending Cash Position of MXN1,096 Mil as of Jun. 2026. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Tandem Diabetes Care and its competitors.
Is Tandem Diabetes Care's Ending Cash Position too high?
Tandem Diabetes Care's current Ending Cash Position is MXN1,096 Mil. Overall, Tandem Diabetes Care has a GF Score™ of 69/100, reflecting its overall financial health beyond just this single metric.
How does Tandem Diabetes Care's Ending Cash Position compare to CNMD and ATEC?
Tandem Diabetes Care's Ending Cash Position of MXN1,096 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Medical Devices & Instruments company?
A good Ending Cash Position depends on the Medical Devices & Instruments industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Tandem Diabetes Care and its competitors. Tandem Diabetes Care's current Ending Cash Position is MXN1,096 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tandem Diabetes Care stock overvalued right now?
Tandem Diabetes Care (MEX:TNDM) has a current Ending Cash Position of MXN1,096 Mil. The stock's GF Value™ is MXN835.73, compared to a current price of MXN745.00 — trading 10.9% below its estimated fair value. The current Ending Cash Position is MXN1,096 Mil. Tandem Diabetes Care's overall GF Score™ is 69/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For Tandem Diabetes Care (MEX:TNDM), the current Ending Cash Position is MXN1,096 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Tandem Diabetes Care (MEX:TNDM) Overvalued in 2026?

Based on GuruFocus' analysis, Tandem Diabetes Care stock appears to be undervalued. The current stock price of MXN745.00 is trading 10.9% below its estimated GF Value™ of MXN835.73.

Key valuation signals for MEX:TNDM:

  • Ending Cash Position: MXN1,096 Mil
  • GF Value™: MXN835.73 vs. price of MXN745.00 (10.9% below fair value)
  • GF Score™: 69/100 with 6 warning signs

No single metric tells the full story. See the MEX:TNDM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Tandem Diabetes Care Business Description

Address 12400 High Bluff Drive, San Diego, CA, USA, 92130
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on Tobi (a tubeless version of Mobi), and the Sigi tubeless patch pump. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 2 to 3 days.
69GF Score

Get the complete analysis for MEX:TNDM

Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN745.00
Price
MXN835.73
GF Value